Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ikai, 2007, Report of the 17th nationwide follow-up survey of primary liver cancer in Japan, Hepatol Res, 37, 676, 10.1111/j.1872-034X.2007.00119.x
Shiina, 2005, A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma, Gastroenterology, 129, 122, 10.1053/j.gastro.2005.04.009
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998;28:751–755.
Llovet, 1999, Prognosis of hepatocellular carcinoma: the BCLC staging classification, Semin Liver Dis, 19, 329, 10.1055/s-2007-1007122
Kudo, 2003, Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan integrated staging score (JIS score), J Gastroenterol, 38, 207, 10.1007/s005350300038
Tateishi, 2005, Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients, Gut, 54, 419, 10.1136/gut.2003.035055
Thorgeirsson, 2002, Molecular pathogenesis of human hepatocellular carcinoma, Nat Genet, 31, 339, 10.1038/ng0802-339
Villanueva, 2007, Genomics and signaling pathways in hepatocellular carcinoma, Semin Liver Dis, 27, 55, 10.1055/s-2006-960171
Kusano, 2002, Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma, Cancer, 94, 746, 10.1002/cncr.10254
Katoh, 2005, Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome, J Hepatol, 43, 863, 10.1016/j.jhep.2005.05.033
Tornillo, 2000, Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas, J Pathol, 192, 307, 10.1002/1096-9896(2000)9999:9999<::AID-PATH706>3.0.CO;2-O
Patil, 2005, Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma, Carcinogenesis, 26, 2050, 10.1093/carcin/bgi178
Huang, 2006, Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma, FEBS Lett, 580, 3571, 10.1016/j.febslet.2006.05.032
Zhao, 2004, An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays, Cancer Res, 64, 3060, 10.1158/0008-5472.CAN-03-3308
Nannya, 2005, A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays, Cancer Res, 65, 6071, 10.1158/0008-5472.CAN-05-0465
Midorikawa, 2006, Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays, Oncogene, 25, 5581, 10.1038/sj.onc.1209537
Moskaluk, 1997, Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections, Am J Pathol, 150, 1547
Yamamoto, 2007, Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays, Am J Hum Genet, 81, 114, 10.1086/518809
Ohta, 2005, p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells, Cancer Res, 65, 10822, 10.1158/0008-5472.CAN-05-0777
Smyth, 1999, Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32, Hum Mol Genet, 8, 291, 10.1093/hmg/8.2.291
Zhang, 1993, Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma, Biochem Biophys Res Commun, 196, 1010, 10.1006/bbrc.1993.2350
Nishida, 1994, Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma, Cancer Res, 54, 3107
Heidenblad, 2002, Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification, Genes Chromosomes Cancer, 34, 211, 10.1002/gcc.10063
Trauzold, 2003, PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells, Oncogene, 22, 8939, 10.1038/sj.onc.1207001
van Dartel, 2002, Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma, Cancer Genet Cytogenet, 139, 91, 10.1016/S0165-4608(02)00627-1
Allikmets, 2000, Simple and complex ABCR: genetic predisposition to retinal disease, Am J Hum Genet, 67, 793, 10.1086/303100
De Valck, 1999, The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases, Oncogene, 18, 4182, 10.1038/sj.onc.1202787
Peters, 2002, Mutation of a transcription factor, TFCP2L3, causes progressive autosomal dominant hearing loss, DFNA28, Hum Mol Genet, 11, 2877, 10.1093/hmg/11.23.2877
Dowler, 2000, Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities, Biochem J, 351, 19, 10.1042/bj3510019
Walker, 2001, Characterization of MTMR3. An inositol lipid 3-phosphatase with novel substrate specificity, Curr Biol, 11, 1600, 10.1016/S0960-9822(01)00501-2
Yasui, 2002, TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas, Hepatology, 35, 1476, 10.1053/jhep.2002.33683
Zimonjic, 1999, Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization, Hepatology, 29, 1208, 10.1002/hep.510290410
Yuan, 1998, Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP, Cancer Res, 58, 2196
Piao, 1997, Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma, Cancer, 80, 865, 10.1002/(SICI)1097-0142(19970901)80:5<865::AID-CNCR6>3.0.CO;2-K
Jin, 2000, p16 is a major inactivation target in hepatocellular carcinoma, Cancer, 89, 60, 10.1002/1097-0142(20000701)89:1<60::AID-CNCR9>3.0.CO;2-3
Hsu, 1994, Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients, Cancer, 73, 42, 10.1002/1097-0142(19940101)73:1<42::AID-CNCR2820730109>3.0.CO;2-D
Melchiorri, 1994, Diagnostic and prognostic value of DNA ploidy and cell nuclearity in ultrasound-guided liver biopsies, Cancer, 74, 1713, 10.1002/1097-0142(19940915)74:6<1713::AID-CNCR2820740612>3.0.CO;2-O
Cottier, 1994, Prospective flow cytometric DNA analysis of hepatocellular carcinoma specimens collected by ultrasound-guided fine needle aspiration, Cancer, 74, 599, 10.1002/1097-0142(19940715)74:2<599::AID-CNCR2820740211>3.0.CO;2-H
Mise, 1998, Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinico-pathological factors and prognosis, Clin Cancer Res, 4, 1475
Marchio, 1997, Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization, Genes Chromosomes Cancer, 18, 59, 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0
Wong, 1999, Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis, Am J Pathol, 154, 37, 10.1016/S0002-9440(10)65248-0
Kusano, 1999, Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinico-pathological features, Hepatology, 29, 1858, 10.1002/hep.510290636
Guan, 2000, Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization, Genes Chromosomes Cancer, 29, 110, 10.1002/1098-2264(2000)9999:9999<::AID-GCC1022>3.0.CO;2-V
Poon, 2000, Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma, Cancer, 89, 500, 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O
Kumada, 1997, Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma, Hepatology, 25, 87, 10.1002/hep.510250116